In order to determine if Rap1A signaling is involved in LPA-mediated breast cancer cell invasion, we depleted Rap1A from the highly aggressive breast cancer MDA-MB-231 cells by stably expressing two individual Rap1A shRNA constructs (shRNA-1 and shRNA-2). The gene discussed is RAP1A; the disease is breast carcinoma.